High acetylsalicylic acid dosing in infants after modified Blalock–Taussig shunt

Abstract Objective Shunt-related adverse events are frequent in infants after modified Blalock–Taussig despite use of acetylsalicylic acid prophylaxis. A higher incidence of acetylsalicylic acid-resistance and sub-therapeutic acetylsalicylic acid levels has been reported in infants. We evaluated whether using high-dose acetylsalicylic acid can decrease shunt-related adverse events in infants after modified Blalock–Taussig. Methods In this single-centre retrospective cohort study, we included infants ⩽1-year-old who underwent modified Blalock–Taussig placement and received acetylsalicylic acid in the ICU. We defined acetylsalicylic acid treatment groups as standard dose (⩽7 mg/kg/day) and high dose (⩾8 mg/kg/day) based on the initiating dose. Results There were 34 infants in each group. Both groups were similar in age, gender, cardiac defect type, ICU length of stay, and time interval to second stage or definitive repair. Shunt interventions (18 versus 32%, p=0.16), shunt thrombosis (14 versus 17%, p=0.74), and mortality (9 versus 12%, p=0.65) were not significantly different between groups. On multiple logistic regression analysis, single-ventricle morphology (odds ratio 5.2, 95% confidence interval of 1.2–23, p=0.03) and post-operative red blood cells transfusion ⩾24 hours [odds ratio 15, confidence interval of (3–71), p<0.01] were associated with shunt-related adverse events. High-dose acetylsalicylic acid treatment [odds ratio 2.6, confidence interval of (0.7–10), p=0.16] was not associated with decrease in these events. Conclusions High-dose acetylsalicylic acid may not be sufficient in reducing shunt-related adverse events in infants after modified Blalock–Taussig. Post-operative red blood cells transfusion may be a modifiable risk factor for these events. A randomised trial is needed to determine appropriate acetylsalicylic acid dosing in infants with modified Blalock–Taussig.

[1]  A. Agarwal,et al.  Incidence and Management of Thrombotic and Thromboembolic Complications Following the Norwood Procedure: A Systematic Review , 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  J. Seghatchian,et al.  Red blood cell storage time and transfusion: current practice, concerns and future perspectives. , 2017, Blood transfusion = Trasfusione del sangue.

[3]  E. Bacha,et al.  The effects of postoperative hematocrit on shunt occlusion for neonates undergoing single ventricle palliation , 2017, The Journal of thoracic and cardiovascular surgery.

[4]  Michael F Swartz,et al.  Outcomes Using a Conservative Versus Liberal Red Blood Cell Transfusion Strategy in Infants Requiring Cardiac Operation. , 2017, The Annals of thoracic surgery.

[5]  X. Sheng,et al.  Platelet Inhibition in Shunted Infants on Aspirin at Short and Midterm Follow-Up , 2017, Pediatric Cardiology.

[6]  D. Redford,et al.  Effects of profound hypoxemia on coagulation & fibrinolysis in normal individuals , 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  C. Télion,et al.  Age dependency for coagulation parameters in paediatric populations , 2016, Thrombosis and Haemostasis.

[8]  T. Ciach,et al.  Surface modification and endothelialization of polyurethane for vascular tissue engineering applications: a review. , 2016, Biomaterials science.

[9]  C. Romagnoli,et al.  Neonatal Platelet Function. , 2015, Clinics in perinatology.

[10]  M. Rettiganti,et al.  Association of haematocrit and red blood cell transfusion with outcomes in infants with shunt-dependent pulmonary blood flow and univentricular physiology. , 2015, Blood transfusion = Trasfusione del sangue.

[11]  S. Frank,et al.  Aspirin Resistance in Single-Ventricle Physiology: Aspirin Prophylaxis Is Not Adequate to Inhibit Platelets in the Immediate Postoperative Period. , 2015, The Annals of thoracic surgery.

[12]  R. Ascuitto,et al.  Computational Fluid Dynamics Characterization of Blood Flow in Central Aorta to Pulmonary Artery Connections: Importance of Shunt Angulation as a Determinant of Shear Stress-Induced Thrombosis , 2015, Pediatric Cardiology.

[13]  S. Emani,et al.  Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery. , 2014, The Journal of thoracic and cardiovascular surgery.

[14]  K. Kanter,et al.  In-hospital shunt occlusion in infants undergoing a modified blalock-taussig shunt. , 2013, The Annals of thoracic surgery.

[15]  J. Gornbein,et al.  Increased Red Blood Cell Transfusions Are Associated with Worsening Outcomes in Pediatric Heart Transplant Patients , 2013, Anesthesia and analgesia.

[16]  B. McCrindle,et al.  Thrombotic complications and thromboprophylaxis across all three stages of single ventricle heart palliation. , 2012, The Journal of pediatrics.

[17]  B. McCrindle,et al.  Longer blood storage is associated with suboptimal outcomes in high-risk pediatric cardiac surgery. , 2012, The Annals of thoracic surgery.

[18]  S. Vesely,et al.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[19]  N. Brown,et al.  Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology , 2011, Intensive Care Medicine.

[20]  R. Kornowski,et al.  Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. , 2010, Journal of the American College of Cardiology.

[21]  C. Brizard,et al.  Activation of platelets in young infants during cardiopulmonary bypass , 2009, Thrombosis and Haemostasis.

[22]  A. Parry,et al.  Risk factors for acute shunt blockage in children after modified Blalock-Taussig shunt operations , 2010, Heart and Vessels.

[23]  Usman Ahmad,et al.  Modified Blalock-Taussig shunt: immediate and short-term follow-up results in neonates. , 2008, Heart, lung & circulation.

[24]  C. Ramaciotti,et al.  Aspirin Resistance in Children with Heart Disease at Risk for Thromboembolism: Prevalence and Possible Mechanisms , 2008, Pediatric Cardiology.

[25]  N. B. Lerner,et al.  Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. , 2007, The Annals of thoracic surgery.

[26]  R. Califf,et al.  Clinical Outcomes of Palliative Surgery Including a Systemic-to-Pulmonary Artery Shunt in Infants With Cyanotic Congenital Heart Disease: Does Aspirin Make a Difference? , 2007, Circulation.

[27]  Justin T. Newcomer,et al.  Evaluation of Dose-Related Effects of Aspirin on Platelet Function: Results From the Aspirin-Induced Platelet Effect (ASPECT) Study , 2007, Circulation.

[28]  S. Chauhan,et al.  Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease. , 2007, Journal of cardiothoracic and vascular anesthesia.

[29]  F. Pigula,et al.  Interim mortality in infants with systemic-to-pulmonary artery shunts. , 2003, The Annals of thoracic surgery.

[30]  A. Michelson,et al.  Neonatal Platelets Are Less Reactive than Adult Platelets to Physiological Agonists in Whole Blood , 1994, Thrombosis and Haemostasis.

[31]  E. Shinebourne,et al.  Serum immunoreactive erythropoietin in children with cyanotic and acyanotic congenital heart disease. , 1987, Blood.

[32]  S. Mace,et al.  Hepatic dysfunction and cardiovascular abnormalities. Occurrence in infants, children, and young adults. , 1985, American journal of diseases of children.